TheWookly
  • Home
  • News
  • Politics
  • Business
  • Culture
  • Opinion
  • Lifestyle
No Result
View All Result
TheWookly
Home Top News

T Cell Treatments For Multiple Sclerosis

Sandra Williams by Sandra Williams
August 2, 2021
in Top News
0
T Cell Treatments For Multiple Sclerosis
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Around 2.8 million people around the world are affected by MS (Multiple sclerosis). This is a disease where the immune system of your body starts attacking your CNS( central nervous system) also called the spinal cord. This is caused when the immune system attacks myelin, a protective sheath that covers the nerve fibers that causes poor communication between your brain and the rest of the body. 

T Cell Treatments For Multiple Sclerosis

People with MS may go through a variety of symptoms. Some may even lose the ability to walk if the condition gets out of hand. The most commonly seen symptoms of multiple sclerosis are difficulty in walking, fatigue, muscle spasms, problems with vision, tremors, electric-shock sensations from the neck, slurred speech, etc.

Related posts

Matt Bomer's

Matt Bomer’s Bio, Childhood, Marriage, Height, Age, Weight, Social Media, And More

March 30, 2022
chris rock

Chris Rock American Comedian Bio,Career,Marrige,Net Worth,Height,Weight,Social Media

March 30, 2022
T Cell Treatments For Multiple Sclerosis

Treg cells and piezo 1 part in  MS

T cells also called white blood cells to play an important role in MS. white blood cells are a part of the body’s immune response. These white blood cells release different compounds that enter the CNS which causes inflammation and causes damage to cells.  Among the different types of t-cells, a certain type called regulatory t-cells or Treg cells is focused on for the MS. These cells regulate and maintain immune homeostasis. Autoimmune diseases can be prevented if the regulatory t cells perform well. And one of the reasons for MS is that these cells do not function well. And this can lead to inflammation and attacks on the central nervous system. 

Piezo 1 which is the main requirement for bone formation has been now found to affect t-cells. Piezo 1 is a specialized protein also called an ion channel that helps with wound healing, bacterial infection and is also seen to be effective in the treatment of cancer. Controlling these piezo 1 ion channels can open new doors in treating MS using Treg cells says, researchers. 

Researchers have found that inhibiting piezo 1 can be effective in the treatment of multiple sclerosis. To test this out, an experiment was conducted with mice. Researchers tested this out on mice with an animal equivalent of ms and they were able to delete piezo 1 genetically. They compared this batch with ones that had piezo 1. They used immune cell imagine and other methods to study them. And they found out that the deletion of piezo 1 has no impact on other cells except on the regulatory t-cells. 

They also found that the mice who did not have piezo 1 should have greater levels of regulatory cells. The study concludes that “ The results indicate that piezo 1 selectively restrains Treg cells, without influencing activation events or effector t cell function”. 

They found that the disease was less intense in the deleted piezo 1 mice. Dr.othy said that they think inhibiting piezo 1 might be the new way to treat multiple sclerosis. It also said that intensive research is necessary before they reach any conclusion. This gives new hope to millions of people waiting for a treatment that can fully cure the disease. Finding how to inhibit piezo 1 in the human body will be the next big advancement towards curing MS.

Related

Tags: Featured

POPULAR NEWS

  • Torroband-review

    Torroband Reviews – For Total Body Workout Solution?

    0 shares
    Share 0 Tweet 0
  • 10 Meal Prep Ideas for Vegans

    0 shares
    Share 0 Tweet 0
  • Master Needs Some Help! Release Date

    0 shares
    Share 0 Tweet 0
  • Q2 2022 HCA Healthcare, Inc. Earnings Forecast for (NYSE:HCA) released by SVB Leerink

    0 shares
    Share 0 Tweet 0
  • B. Riley Financial: Capital markets activities fuel long-term revenue growth (NASDAQ:RILY)

    0 shares
    Share 0 Tweet 0
Facebook Twitter Youtube Pinterest

Useful Links

  • About
  • Contact
  • Advertise
  • Privacy Policy
  • Disclaimer
  • Terms and Conditions

About Us

Let it be entertainment, business, politics, or tech, The Wookly provides you with the latest news about everything happening all around the globe.

Copyright © 2022 TheWookly. All Rights Reserved

No Result
View All Result
  • Home
  • Politics
  • News
  • Business
  • Culture
  • National
  • Sports
  • Lifestyle
  • Travel
  • Opinion

Copyright © 2022 TheWookly. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
SAVE & ACCEPT